MEG3 is an inhibitor of the cell proliferation, interacting, for example, with p53, and the likely loss of the expressed copy (reflected on the expression of genes and micro RNA’s and methylation changes) would unsurprisingly imply an effect on the variance and stage classification of the ACC tumors. This evidence concerns the gene MEG3 and adrenal cortex carcinoma.